BCL6 and cancer: An inducible transgenic mouse model that is doubly transgenic for the tetracycline-responsive tet-o-bcl6 gene and the tissue-specific tetracycline-transactivating protein EμSR-tTA has been constructed to investigate the role of Bcl6 in this type of cancer in detail (57).